Cargando…

Protocol for an economic evaluation of the randomised controlled trial of culprit lesion only PCI versus immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: CULPRIT-SHOCK trial

INTRODUCTION: Emergency percutaneous coronary intervention (PCI) of the culprit lesion for patients with acute myocardial infarctions is an accepted practice. A majority of patients present with multivessel disease with additional relevant stenoses apart from the culprit lesion. In haemodynamically...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quayyum, Zahidul, Briggs, Andrew, Robles-Zurita, Jose, Oldroyd, Keith, Zeymer, Uwe, Desch, Steffen, de Waha, Suzanne, Thiele, Holger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Health Economics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724099/ https://www.ncbi.nlm.nih.gov/pubmed/28821512 http://dx.doi.org/10.1136/bmjopen-2016-014849

Ejemplares similares

Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial
por: Robles-Zurita, Jose Antonio, et al.
Publicado: (2020)

Multivessel versus culprit-only PCI in STEMI patients with multivessel disease: meta-analysis of randomized controlled trials
por: Feistritzer, Hans-Josef, et al.
Publicado: (2020)

Outcomes Associated with Respiratory Failure for Patients with Cardiogenic Shock and Acute Myocardial Infarction: A Substudy of the CULPRIT-SHOCK Trial
por: Rubini Giménez, Maria, et al.
Publicado: (2020)

Prognostic Impact of Active Mechanical Circulatory Support in Cardiogenic Shock Complicating Acute Myocardial Infarction, Results from the Culprit-Shock Trial
por: Feistritzer, Hans-Josef, et al.
Publicado: (2020)

Multivessel Intervention in Myocardial Infarction with Cardiogenic Shock: CULPRIT-SHOCK Trial Outcomes in the PL-ACS Registry
por: Gąsior, Mariusz, et al.
Publicado: (2021)

Impact of Center Volume on Outcomes in Myocardial Infarction Complicated by Cardiogenic Shock: A CULPRIT‐SHOCK Substudy
por: Schrage, Benedikt, et al.
Publicado: (2021)

Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock
por: Hemradj, Veemal V., et al.
Publicado: (2020)

Multivessel vs. culprit vessel-only percutaneous coronary intervention in ST-segment elevation myocardial infarction with and without cardiogenic shock
por: Wu, Jing, et al.
Publicado: (2022)

Clopidogrel vs. prasugrel vs. ticagrelor in patients with acute myocardial infarction complicated by cardiogenic shock: a pooled IABP-SHOCK II and CULPRIT-SHOCK trial sub-analysis
por: Orban, Martin, et al.
Publicado: (2021)

Culprit‐Only Versus Immediate Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicating Advanced Cardiogenic Shock Requiring Venoarterial‐Extracorporeal Membrane Oxygenation
por: Choi, Ki Hong, et al.
Publicado: (2023)

Multi-vessel Versus Culprit-vessel-only PCI for STEMI: Where Does the Jury Stand?
por: Almas, Talal, et al.
Publicado: (2021)

Preventive PCI versus culprit lesion stenting during primary PCI in acute STEMI: a systematic review and meta-analysis
por: Pandit, Anil, et al.
Publicado: (2014)

Importance of swift event adjudication of endpoints for adequate reporting to data and safety monitoring boards in clinical trials—lessons from CULPRIT-SHOCK
por: Clemmensen, Peter, et al.
Publicado: (2021)

Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study
por: Mangion, Kenneth, et al.
Publicado: (2015)

Multivessel vs. Culprit Vessel-Only Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction in Patients With Cardiogenic Shock: An Updated Systematic Review and Meta-Analysis
por: Xiong, Bingquan, et al.
Publicado: (2022)

Left ventricular outcomes following multivessel PCI vs. infarct artery-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study
por: Mangion, Kenneth, et al.
Publicado: (2015)

A case report: unmasking a singular culprit for cardiogenic shock: looking beyond the coronary tree
por: Almeida-Morais, Luís, et al.
Publicado: (2019)

Prognosis of cardiogenic shock secondary to culprit left main coronary artery lesion‐related myocardial infarction
por: Galván‐Román, Francisco, et al.
Publicado: (2022)

Non-culprit left main coronary artery disease in acute myocardial infarction complicated by cardiogenic shock
por: Park, Ik Hyun, et al.
Publicado: (2023)

Management of Non-Culprit Lesions in STEMI Patients with Multivessel Disease
por: Piccolo, Raffaele, et al.
Publicado: (2023)

Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial
por: Fuernau, Georg, et al.
Publicado: (2014)

Prognosis of STEMI Patients with Multi-Vessel Disease Undergoing Culprit-Only PCI without Significant Residual Ischemia on Non-Invasive Stress Testing
por: Weissler-Snir, Adaya, et al.
Publicado: (2015)

Unprotected Left Main Primary PCI via Distal Transradial Access in the Setting of STEMI-Related Cardiogenic Shock
por: Oliveira, Marcos Danillo Peixoto, et al.
Publicado: (2021)

Culprit vessel vs. immediate multivessel vs. out-of-hospital staged intervention for patients with non-ST-segment elevation myocardial infarction and multivessel disease
por: Wang, Chen, et al.
Publicado: (2022)

Impact of IVUS Guidance on Single-Session vs Staged Multivessel PCI
por: Ozaki, Yukio
Publicado: (2023)

Culprit Vessel Only versus Multivessel Percutaneous Coronary Intervention in Patients Presenting with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
por: Zhang, Dongfeng, et al.
Publicado: (2014)

Rapid progression of nonculprit coronary lesions six weeks after successful primary PCI in culprit artery: a case report
por: Tang, Jianjin, et al.
Publicado: (2014)

Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction
por: Lee, Myunhee, et al.
Publicado: (2021)

A Cardiogenic Shock due to an Acute MI with LCA Arising from the Right Coronary Sinus Successfully Treated with PCI
por: Jadeed, Rayyan, et al.
Publicado: (2019)

Thrombus Aspiration in ThrOmbus containing culpRiT lesions in Non-ST-Elevation Myocardial Infarction (TATORT-NSTEMI): study protocol for a randomized controlled trial
por: de Waha, Suzanne, et al.
Publicado: (2013)

Correction: Culprit Vessel Only versus Multivessel Percutaneous Coronary Intervention in Patients Presenting with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
Publicado: (2014)

Correction: Culprit Vessel Only versus Multivessel Percutaneous Coronary Intervention in Patients Presenting with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
Publicado: (2014)

Challenges in the conduct of randomised controlled trials in cardiogenic shock complicating acute myocardial infarction
por: Freund, Anne, et al.
Publicado: (2022)

Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight
por: Bhatt, Deepak L, et al.
Publicado: (2001)

Complete revascularization with PCI in STEMI patients with multivessel disease, when is the appropriate time?
por: Aquino-Bruno, Heberto, et al.
Publicado: (2023)

New debate of revascularization strategy of non-infarct-related artery lesions in patients with ST-segment elevation myocardial infarction and cardiogenic shock: decoding the CULPRIT-SHOCK trial, not enough to challenge the current guidelines
por: Song, Fang, et al.
Publicado: (2019)

Percutaneous Coronary Intervention (PCI) Strategies under Hemodynamic Support for Cardiogenic Shock: A Single-Center Experience with Two Patients
por: Ahmed, Talha, et al.
Publicado: (2020)

Multivessel versus Culprit-Only Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome
por: Pustjens, Tobias F. S., et al.
Publicado: (2022)

Multivessel coronary thrombosis in a COVID-19 patient: Lungs are not always a culprit
por: Kuzemczak, Michał, et al.
Publicado: (2021)

Complete versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: a meta-analysis of randomized trials
por: Xu, Haiyan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rj3f5098jk1qrn7fvvka76fbut